Or can the same effects be achieved, sans medication
Matthias Endres: ME reports funding from the DFG via KFO 5023 BeCAUSE-Y, project 2 EN343/16-1 Poster Session II - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION 06.00 - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION - 06.02 - GENETICS, OMICS AND BIOMARKERS P1057 - ESOC25-2297 LONGITUDINAL ANALYSIS OF PLASMA SMALL RNAS PREDICT STROKE OUTCOMES Ana Moutinho 1,2,3 , Alexandre Dias 1,2 , Marta Ferreira 1,4 , Catarina Vaz 5 , Ricardo Varela 5 , Rui Felgueiras 5 , Joana Lopes 5 , Pedro Castro 6 , Bruno Castro 6 , Rui Magalhes 2 , Manuel Correia 2,5 , Joo Vinagre 1,3,7 , Carla Oliveira 1,7 , Lus Maia 1,2,5 1 i3S - Instituto de Investigao e Inovao em Sade, Universidade do Porto, Porto, Portugal, 2 Instituto de Cincias Biomdicas Abel Salazar, Porto, Portugal, 3 U-Monitor, Porto, Portugal, 4 Faculdade de Cincias da Universidade do Porto, Porto, Portugal, 5 Servio de Neurologia, Centro Hospitalar Universitrio de Santo Antnio, Porto, Portugal, 6 Servio de Neurologia, Centro Hospitalar Universitrio de So Joo, Porto, Portugal, 7 IPATIMUP - Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal Background and Aims: Stroke diagnosis and prognosis rely on neuroimaging and clinical assessments, which have limitations
Where the line becomes bright is treatment
Based on findings, medication adjustments, nutritional supplementation, or referral to specialist services may be recommended
